SHORT ON $CNX (CONSOL ENERGY)

As per our earlier post regarding coal shipment data on the rail roads, our methodology dictated short sell on $CNX from $52.80 as the price pattern appeared to start a double top. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE

Read More

$AMGN IS APPROACHING THE SUPPORT AREA, MORE SCALE OUT AT $55.90

www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized

Read More

CONTINUE SCALING OUT OF $AMGN AS THE STOCK FALLS

Consider scaling out more $AMGN right here around $56.42 www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning

Read More

$AMGN ( AMGEN ) EARNINGS PROVE OUR LONGSTANDING THESIS CORRECT.

We have been short on $AMGN. Details in the earnings report prove our thesis to be correct. However in view of the generally bullish market, we suggest taking partial profits right here at $56.92 and tightening the stop band on the rest. Consider exiting the position by scaling out. www.thearorareport.com

Read More

$BSX (BOSTON SCIENTIFIC) EARNINGS CONFIRM OUR SHORT SELL THESIS

We have been short on $MDT (Medtronics) with the first scale in at $36.20 and more aggressive entry at $38.00. $BSX earnings show weakness in both stents and implantable cardiac devices. Going forward guidance for US is quite a bit lower than expected. This confirms our thesis and we will

Read More

CONSIDER EXITING $NUVA (NUVASIVE) RIGHT HERE AT $43.50 AS THE STOCK HAS REACHED OUR TARGET FOT THIS VERY SHORT TERM TRADE

www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized

Read More

OUT OF THE REMAINING $INTC (INTEL) SHORT POSITION WITH A PROFIT

The plan was to keep on lowering the stops and progressively tightening them. As INTC approached $20, it was either going to spike down through it on panic selling or bounce higher, thus making a tight stop at $20.11 lot of sense. The stop hit and the trade is done.

Read More

RAISE STOPS ON $NUVA (NUVASIVE)

www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized

Read More

TAKE MORE PROFITS ON $INTC (INTEL) SHORT POSITION RIGHT HERE AT $20.56 AND TIGHTEN THE STOPS ON THE REST

www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized

Read More

WOW! FDA AGREES WITH OUR LONGSTANDING ASSESSMENT OF FAMPRIDINE-SR , SHORT SELL $ACOR (ACORDIA) PER OUR PRIOR POST

www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized

Read More

A fortune is to be made from AI stocks.
Get the list of 18 AI stocks to grab your share of the profits — no cost to you.

A fortune is to be made from AI stocks.

Get the list of 18 AI stocks to grab your share of the profits.

AI is a $1 Trillion Market

Making A Fortune
In Artificial Intelligence

Golden Age of Artificial Intelligence

Skip to content